Maxcyte Inc (MXCT) returns
Maxcyte returns over 5 years
$1,000 invested in Maxcyte five years ago was worth $141.46 at the close on October 30, 2026, with dividends reinvested: an average return of -32.4% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +42.0% | — | $1,420 | -0.9% |
| 3 months | +51.4% | — | $1,514 | +2.1% |
| Year to date | +2.6% | — | $1,026 | +11.7% |
| 1 year | +5.3% | — | $1,053 | +12.4% |
| 3 years | -46.3% | -18.7% | $537.16 | +88.5% |
| 5 years | -85.9% | -32.4% | $141.46 | +76.0% |
Maxcyte return by calendar year
| Year | MXCT | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +2.6% | +11.7% | -9.1% |
| 2025 | -62.7% | +17.7% | -80.5% |
| 2024 | -11.5% | +24.9% | -36.4% |
| 2023 | -13.9% | +26.2% | -40.1% |
| 2022 | -46.4% | -18.2% | -28.2% |
| 2021 | +525.2% | +28.7% | +496.4% |
| 2020 | 0.0% | +18.4% | -18.4% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: MXCT financials
No forecast, no recommendation. This page describes Maxcyte Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.